AUSTIN, TX & PHILADELPHIA, PA — Faeth Therapeutics and The GOG Foundation, Inc. have announced a significant milestone in the ...

Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...

Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

There are several categories of endometrial cancer, including: Endometrioid cancer. This is by far the most common type. It starts in the glands of the endometrium. Under a microscope ...

7 This cohort study used U.S. Cancer Statistics data on endometrioid endometrial cancer from 2001 to 2018 (n=586,742), which included 493,315 cases (84.1%) in White women, 48,034 (8.5% ...

PD-1 blockade conferred benefit to certain women with surgically resectable endometrial cancer, findings presented at Society ...

Conclusions Trop-2 protein overexpression is significantly associated with higher tumor grade and serves as an independent prognostic factor for DFS in endometrioid endometrial cancer.

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient, surgically resectable endometrial cancer.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding ...

The research team also assessed mutation rates for genes that are not included in a cancer type’s standard-of-care testing protocol. For example, 54 percent of uterine corpus endometrial carcinomas ...